Literature DB >> 17199135

Global analysis of differentially expressed genes in androgen-independent prostate cancer.

Q Wei1, M Li, X Fu, R Tang, Y Na, M Jiang, Y Li.   

Abstract

Progression to androgen independent (AI) is the main cause of death in prostate cancer, and the mechanism is still unclear. By reviewing the expression profiles of 26 prostate cancer samples in a holistic view, we found a group of genes differentially expressed in AI compared with androgen-dependent groups (P-value<0.01, t-test). Focusing on apoptosis, proliferation, hormone and angiogenesis, we found a group of genes such as thioredoxin domain containing 5 , tumor necrosis factor receptor superfamily, member 10a , ribosomal protein S19 and Janus kinase 2 upregulated in AI prostate cancer, could play important roles in the transition from AD to AI and could be biomarkers of prognosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17199135     DOI: 10.1038/sj.pcan.4500933

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  14 in total

1.  The influence of TXNDC5 gene on gastric cancer cell.

Authors:  Lin Zhang; Yanhong Hou; Nan Li; Kai Wu; Junshan Zhai
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-16       Impact factor: 4.553

2.  The role of TXNDC5 in castration-resistant prostate cancer-involvement of androgen receptor signaling pathway.

Authors:  L Wang; G Song; X Chang; W Tan; J Pan; X Zhu; Z Liu; M Qi; J Yu; B Han
Journal:  Oncogene       Date:  2014-12-15       Impact factor: 9.867

Review 3.  Androgens, aging, and prostate health.

Authors:  Karin Welén; Jan-Erik Damber
Journal:  Rev Endocr Metab Disord       Date:  2022-06-24       Impact factor: 6.514

4.  Identifying gene-disease associations using centrality on a literature mined gene-interaction network.

Authors:  Arzucan Ozgür; Thuy Vu; Günes Erkan; Dragomir R Radev
Journal:  Bioinformatics       Date:  2008-07-01       Impact factor: 6.937

5.  LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancer.

Authors:  Tammy L Romanuik; Gang Wang; Olena Morozova; Allen Delaney; Marco A Marra; Marianne D Sadar
Journal:  BMC Med Genomics       Date:  2010-09-24       Impact factor: 3.063

6.  Transcriptional signatures of Ral GTPase are associated with aggressive clinicopathologic characteristics in human cancer.

Authors:  Steven C Smith; Alexander S Baras; Charles R Owens; Garrett Dancik; Dan Theodorescu
Journal:  Cancer Res       Date:  2012-05-14       Impact factor: 12.701

7.  Gene expression feature selection for prostate cancer diagnosis using a two-phase heuristic-deterministic search strategy.

Authors:  Saleh Shahbeig; Akbar Rahideh; Mohammad Sadegh Helfroush; Kamran Kazemi
Journal:  IET Syst Biol       Date:  2018-08       Impact factor: 1.615

8.  An immunohistochemical study of thioredoxin domain-containing 5 expression in gastric adenocarcinoma.

Authors:  Zhiming Wu; Lin Zhang; Nan Li; Lina Sha; Kunpeng Zhang
Journal:  Oncol Lett       Date:  2014-12-29       Impact factor: 2.967

9.  Early side effects and first results of radioligand therapy with (177)Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study.

Authors:  Hojjat Ahmadzadehfar; Kambiz Rahbar; Stefan Kürpig; Martin Bögemann; Michael Claesener; Elisabeth Eppard; Florian Gärtner; Sebastian Rogenhofer; Michael Schäfers; Markus Essler
Journal:  EJNMMI Res       Date:  2015-06-20       Impact factor: 3.138

10.  Screening key microRNAs for castration-resistant prostate cancer based on miRNA/mRNA functional synergistic network.

Authors:  Jin Zhu; Sugui Wang; Wenyu Zhang; Junyi Qiu; Yuxi Shan; Dongrong Yang; Bairong Shen
Journal:  Oncotarget       Date:  2015-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.